Most Popular Stories
- Federal bill would link Medicare hospital pay to quality
- Express Scripts clients being extorted, too
- Moody's says healthcare's vulnerable to economy's ills
- Obama healthcare plan a plus for hospitals, Moody's says
- Pay for no extra performance?
- Wiebking named new president of Provena; Acclaimed scientist preps first skin cancer vax trial;
Poll
Featured Jobs
-
Chief Privacy Officer, Americas Region
IMS Health Incorporated - Plymouth Meeting, PA -
Tennessee Rheumatologist
StaffPointe, LLC - near Chattanooga , TN -
Nevada Family Practice Physician
StaffPointe, LLC - northwest, NV -
New York Urgent Care
StaffPointe, LLC - east, NY -
New York Rheumatologist
StaffPointe, LLC - east, NY
Events
- World Healthcare Innovation & Technology Congress WHIT v.4.0
Dec 8-10 — Washington, DC - World Health Care Congress
April 14-16, 2009 — Washington, DC
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
Louisiana MDs win legal battle over patient record disclosure
A group of Louisiana physicians have won their battle to keep their patients' records out of the hands of a pharmaceutical company--though they may face future challenges on the issue. The dispute comes as part of the Louisiana attorney general's suit against Janssen Pharmaceutic, which the state says has been illegally promoting off-label uses of Risperdal. The AG also is arguing that in so doing, Janssen defrauded the state's Medicaid program. Though no doctors or patients are parties to the suit, Janssen got a court order allowing it to subpoena physicians for the medical records of up to 6,000 Medicaid beneficiaries who received Risperdal prescriptions. The order also allowed the pharma to depose individual doctors on their Risperdal prescription decisions. However, the state's physicians contested the order, with judges concluding that Louisiana's laws governing medical privacy would invalidate the request.
To learn more about the case:
- read this AMNews article
Related Articles:
Lilly accused of promoting off-label Zyprexa use
Schering fined $435M for off-label marketing
Health plans target off-label use
Medicare patients can't get drugs for off-label uses
Related Stories
- Walgreens settles Medicaid billing allegations
- AstraZeneca asks judge to nullify $215M drug-price lawsuit
- NY Medicaid will stop paying for 'never events'
- FTC: Pharmas cut 14 deals to delay generic sales in '07
- ALSO NOTED: Sutter claims nurse strike won't affect operations; Wash. group pushes for patient care reporting; and much more...
- Merck agrees to pay$650M+ to settle suits
- Statin drug probably not going OTC
- Study: Med school pharma limits affect attitudes
- CMS claims submissions getting cleaner
- Amgen spending millions to fight CMS anemia drug limits
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





